Causal relationship between gastro-esophageal reflux disease and risk of lung cancer: insights from multivariable Mendelian randomization and mediation analysis
- PMID: 37344162
- DOI: 10.1093/ije/dyad090
Causal relationship between gastro-esophageal reflux disease and risk of lung cancer: insights from multivariable Mendelian randomization and mediation analysis
Abstract
Aim: A recent study has reported that anti-reflux surgery reduced the risk of lung cancer. However, the exact causal association between gastro-esophageal reflux disease (GORD) and lung cancer remains obscure. Therefore, we conducted a multivariable and network Mendelian randomization (MR) study to explore this potential association and mediation effect.
Methods: Independent single nucleotide polymorphisms (SNPs) strongly associated with GORD were selected as instrumental variables (IVs) from the corresponding genome-wide association studies (GWAS). The summary statistics were obtained from the largest GORD GWAS meta-analysis of 367 441 (78 707 cases) European individuals, and the summary statistics of lung cancer and pathological subtypes came from International Lung Cancer Consortium (ILCCO) and FinnGen databases. Univariable and multivariable MR analyses were performed to investigate and verify the causal relationship between genetically predicted GORD and lung cancer. Network MR analysis was conducted to reveal the mediating role of GORD between smoking initiation and lung cancer.
Results: The univariable MR analysis demonstrated that GORD was associated with an increased risk of total lung cancer in both ILCCO [inverse variance weighted (IVW): odds ratio (OR) = 1.37, 95% confidence interval (CI) 1.16-1.62, P = 1.70E-04] and FinnGen database (IVW: OR = 1.25, 95% confidence interval CI 1.03-1.52, P = 2.27E-02). The consistent results were observed after adjusting the potential confounders [smoking traits, body mass index (BMI) and type 2 diabetes] in multivariable MR analyses. In subtype analyses, GORD was associated with lung adenocarcinoma (IVW: OR = 1.27, 95% CI 1.02-1.59, P = 3.48E-02) and lung squamous cell carcinomas (IVW: OR = 1.50, 95% CI 1.22-1.86, P = 1.52E-04). Moreover, GORD mediated 32.43% (95% CI 14.18-49.82%) and 25.00% (95% CI 3.13-50.00%) of the smoking initiation effects on lung cancer risk in the ILCCO and FinnGen databases, respectively.
Conclusion: This study provides credible evidence that genetically predicted GORD was significantly associated with an increased risk of total lung cancer, lung adenocarcinoma and lung squamous cell carcinomas. Furthermore, our results suggest GORD is involved in the mechanism of smoking initiation-induced lung cancer.
Keywords: GORD; Lung cancer; Mendelian randomization; risk.
© The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
Similar articles
-
No genetic causal association between human papillomavirus and lung cancer risk: a bidirectional two-sample Mendelian randomization analysis.Trials. 2024 Sep 3;25(1):582. doi: 10.1186/s13063-024-08366-5. Trials. 2024. PMID: 39227966 Free PMC article.
-
Causal associations between gastroesophageal reflux disease and lung cancer risk: A Mendelian randomization study.Cancer Med. 2023 Mar;12(6):7552-7559. doi: 10.1002/cam4.5498. Epub 2022 Dec 8. Cancer Med. 2023. PMID: 36479899 Free PMC article.
-
Genetic estimation of correlations and causalities between multifaceted modifiable factors and gastro-oesophageal reflux disease.Front Nutr. 2022 Nov 1;9:1009122. doi: 10.3389/fnut.2022.1009122. eCollection 2022. Front Nutr. 2022. PMID: 36386930 Free PMC article.
-
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.PLoS Med. 2016 Sep 6;13(9):e1002118. doi: 10.1371/journal.pmed.1002118. eCollection 2016 Sep. PLoS Med. 2016. PMID: 27598322 Free PMC article.
-
Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies.EBioMedicine. 2022 Aug;82:104154. doi: 10.1016/j.ebiom.2022.104154. Epub 2022 Jul 8. EBioMedicine. 2022. PMID: 35816897 Free PMC article.
Cited by
-
Genetic associations between circulating immune cells and periodontitis highlight the prospect of systemic immunoregulation in periodontal care.Elife. 2024 Mar 27;12:RP92895. doi: 10.7554/eLife.92895. Elife. 2024. PMID: 38536078 Free PMC article.
-
Gastroesophageal reflux disease as a risk factor for oral cavity and pharyngeal cancer: a Mendelian randomization study.Discov Oncol. 2025 Mar 18;16(1):353. doi: 10.1007/s12672-025-02105-1. Discov Oncol. 2025. PMID: 40100509 Free PMC article.
-
Integrated multiomics machine learning and mediated Mendelian randomization investigate the molecular subtypes and prognosis lung squamous cell carcinoma.Transl Lung Cancer Res. 2025 Mar 31;14(3):857-877. doi: 10.21037/tlcr-24-891. Epub 2025 Mar 18. Transl Lung Cancer Res. 2025. PMID: 40248728 Free PMC article.
-
SREBF1, a target gene of multiple sclerosis and coronary heart disease: based on mendelian randomization study.Hereditas. 2025 Feb 14;162(1):22. doi: 10.1186/s41065-025-00388-6. Hereditas. 2025. PMID: 39953634 Free PMC article.
-
The immune-related plasma protein LAT2 as a protective modulator in diabetic retinopathy: a Mendelian randomization study.Front Endocrinol (Lausanne). 2025 Jul 17;16:1638661. doi: 10.3389/fendo.2025.1638661. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40747309 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical